These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7791638)

  • 1. The proper use of blood products.
    Nicholls M
    Med J Aust; 1995 Jun; 162(11):564. PubMed ID: 7791638
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood usage review in a Belgian university hospital.
    Schots J; Steenssens L
    Int J Qual Health Care; 1994 Mar; 6(1):41-5. PubMed ID: 7953203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
    Metz J; McGrath KM; Copperchini ML; Haeusler M; Haysom HE; Gibson PR; Millar RJ; Babarczy A; Ferris L; Grigg AP
    Med J Aust; 1995 Jun; 162(11):572-3, 576-7. PubMed ID: 7791642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring for undertransfusion.
    Mair B; Agosti SJ; Foulis PR; Hamilton RA; Benson K
    Transfusion; 1996 Jun; 36(6):533-5. PubMed ID: 8669085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood loss and transfusion requirements in liver transplantation: experience with the first 75 cases.
    McNicol PL; Liu G; Harley ID; McCall PR; Przybylowski GM; Bowkett J; Angus PW; Hardy KJ; Jones RM
    Anaesth Intensive Care; 1994 Dec; 22(6):666-71. PubMed ID: 7892969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective audit of cytomegalovirus-negative blood product utilization in haematology/oncology patients.
    Chang H; Hawes J; Hall GA; Fuller K; Francombe WH; Zuber E; Sher GD
    Transfus Med; 1999 Sep; 9(3):195-8. PubMed ID: 10555812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditoría transfusional en un Hospital de Alta Especialidad. Análisis retrospectivo de 12 meses.
    Cano-Palmeros MÁ; Castañón-González J; Cano-Quevedo MÁ; Morales-Uchino DS; Benavides-González A; Espinosa-Kuri A; Ruiz-Moreno DE
    Gac Med Mex; 2017; 153(7):765-768. PubMed ID: 29414956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year clinical audit of the use of blood and blood components at a tertiary hospital in Nigeria.
    Arewa OP
    Niger J Clin Pract; 2009 Dec; 12(4):429-33. PubMed ID: 20329686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemovigilance is associated with decreased use and improved appropriateness of blood transfusion.
    Cahill MR; Joyce S; O'Brien N; Casey M
    Vox Sang; 2003 Aug; 85(2):121-2. PubMed ID: 12925167
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfusion thresholds and red blood cells transfusion focused on tissue oxygenation.
    Ripollés-Melchor J; García-Erce JA; Vincent JL
    Rev Esp Anestesiol Reanim (Engl Ed); 2018; 65(7):363-365. PubMed ID: 29657065
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring blood transfusion in patients undergoing coronary artery bypass grafting: an audit methodology.
    Grayson AD; Jackson M; Desmond MJ
    Vox Sang; 2003 Aug; 85(2):96-101. PubMed ID: 12925161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion treatment at Sestre Milosrdnice University Hospital Center during a twelve-year period.
    Sović D; Dodig J; Banović M; Jularić A
    Acta Clin Croat; 2014 Sep; 53(3):342-7. PubMed ID: 25509245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective study of the causes for destruction of labile blood products during 1999 at a University Hospital Center].
    Benz-Lemoine E; Baloge B; Dupuis M; Champagne X; Pradeau F; Redersdorff JC
    Transfus Clin Biol; 2001 Dec; 8(6):460-6. PubMed ID: 11802607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood products use in France: a nationwide cross-sectional survey.
    Fillet AM; Desmarets M; Assari S; Quaranta JF; François A; Pugin A; Schuhmacher A; Lassale B; Monnet E; Cabre P; Legrand D; Binda D; Djoudi R
    Transfusion; 2016 Dec; 56(12):3033-3041. PubMed ID: 27807857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of the blood products distribution in France - detailed analysis in a regional blood transfusion centre].
    Py JY; Labbe C; Jutant T; Mouchet C; Roubinet F
    Transfus Clin Biol; 2008 Nov; 15(5):259-65. PubMed ID: 18926755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion practice in Belgium. As assessed by a national survey.
    Beguin C; Lambermont M; Dupont E; Vandermeersch E; France FH; Waterloos H; Baele P
    Acta Anaesthesiol Belg; 1998; 49(2):141-52. PubMed ID: 9675384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collection and transfusion of blood and blood components in the United States, 1992.
    Wallace EL; Churchill WH; Surgenor DM; An J; Cho G; McGurk S; Murphy L
    Transfusion; 1995 Oct; 35(10):802-12. PubMed ID: 7570909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of blood transfusion practice in French-speaking pediatric anesthesiologists.
    Jouffroy R; Baugnon T; Carli P; Orliaguet G
    Paediatr Anaesth; 2011 Apr; 21(4):385-93. PubMed ID: 21299685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of the demographics of blood use.
    Cobain TJ; Vamvakas EC; Wells A; Titlestad K
    Transfus Med; 2007 Feb; 17(1):1-15. PubMed ID: 17266700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronic enhancements to blood ordering reduce component waste.
    Yazer MH; Deandrade DS; Triulzi DJ; Wisniewski MK; Waters JH
    Transfusion; 2016 Mar; 56(3):564-70. PubMed ID: 26559520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.